{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-25-000010","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.364237+00:00","generated_at":"2026-05-27T05:34:44.008972+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Keros CEO Jasbir Seehra to present at Guggenheim SMID Cap Biotech Conference on Feb 6","bullets":["Chair and CEO Jasbir Seehra will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference.","Presentation scheduled for Thursday, February 6, 2025, at 10:00 a.m. Eastern time.","Live webcast and 90-day replay available via Keros investor relations page."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-25-000010","json":"https://secwatch.observer/filing/0001664710-25-000010.json","markdown":"https://secwatch.observer/filing/0001664710-25-000010.md","text":"https://secwatch.observer/filing/0001664710-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471025000010/0001664710-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471025000010/kros-20250130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:34:44.008972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}